TITLE

Toward "Pain-Free" Statin Prescribing: Clinical Algorithm for Diagnosis and Management of Myalgia

AUTHOR(S)
Jacobson, Terry A.
PUB. DATE
June 2008
SOURCE
Mayo Clinic Proceedings;Jun2008, Vol. 83 Issue 6, p687
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Myalgia, which often manifests as pain or soreness in skeletal muscles, is among the most salient adverse events associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins). Clinical issues related to statin-associated myotoxicity include (1) incidence in randomized controlled trials and occurrence in postmarketing surveillance databases; (2) potential differences between statins in their associations with such adverse events; and (3) diagnostic and treatment strategies to prevent, recognize, and manage these events. Data from systematic reviews, meta-analyses, clinical and observational trials, and post-marketing surveillance indicate that statin-associated myalgia typically affects approximately 5.0% of patients, as myopathy in 0.1% and as rhabdomyolysis in 0.01%. However, studies also suggest that myalgia is among the leading reasons patients discontinue statins (particularly high-dose statin monotherapy) and that treatment with certain statins (eg, fluvastatin) is unlikely to result in such adverse events. This review presents a clinical algorithm for monitoring and managing statin-associated myotoxicity. The algorithm highlights risk factors for muscle toxicity and provides recommendations for (1) creatine kinase measurements and monitoring; (2) statin dosage reduction, discontinuation, and rechallenge; and (3) treatment alternatives, such as extended-release fluvastatin with or without ezetimibe, low-dose or alternate-day rosuvastatin, or ezetimibe with or without colesevelam. The algorithm should help to inform and enhance patient care and reduce the risk of myalgia and other potentially treatment-limiting muscle effects that might undermine patient adherence and compromise the overall cardioprotective benefits of statins.
ACCESSION #
32617217

 

Related Articles

  • Engineering practice variation through provider agreement: a cluster-randomized feasibility trial. McCarren, Madeline; Twedt, Elaine L.; Mansuri, Faizmohamed M.; Nelson, Philip R.; Peek, Brian T. // Therapeutics & Clinical Risk Management;2014, Vol. 10, p905 

    Purpose: Minimal-risk randomized trials that can be embedded in practice could facilitate learning health-care systems. A cluster-randomized design was proposed to compare treatment strategies by assigning clusters (eg, providers) to "favor" a particular drug, with providers retaining autonomy...

  • Effectiveness of a tailored intervention to improve cardiovascular risk management in primary care: study protocol for a randomised controlled trial. Huntink, Elke; Heijmans, Naomi; Wensing, Michel; Lieshout, Jan van // Trials;2013, Vol. 14 Issue 1, p2 

    Background Cardiovascular disease (CVD) is an important worldwide cause of mortality. In The Netherlands, CVD is the leading cause of death for women and the second cause of death for men. Recommendations for diagnosis and treatment of CVD are not well implemented in primary care. In this study,...

  • Pharmacists' Research Contributions in the Fight against HIV/AIDs. Horace, Alexis E. // AIDS Research & Treatment;2012, p1 

    Pharmacists have made many contributions to HIV/AIDs research and are still showing their significance as members of the healthcare team through innovative clinical trials. Pharmacists are showing advances in several healthcare settings including inpatient, outpatient, and community pharmacies....

  • Involving patients in clinical trial design. Steimes, Philippe // Applied Clinical Trials;Sep2000, Vol. 9 Issue 9, p94 

    Focuses on the importance of patient involvement in the construction of clinical trial design in France. Role of investigators and sponsors in trial designs; Impact of patient participation on the improvement of clinical trial conditions; Protection of subject rights in the ethical approval of...

  • Paper vs. Electronic Diaries. Hufford, Michael R.; Stone, Arthur A.; Shiffman, Saul; Schwartz, Joseph E.; Broderick, Joan E. // Applied Clinical Trials;Aug2002, Vol. 11 Issue 8, p38 

    Evaluates patient compliance with paper and electronic diaries in clinical trials. Falsification of paper diary cards; Subjects' evaluations of paper and electronic diaries; Patterns of compliance.

  • Test Subjects Foil Some Clinical Trials.  // Journal of Dental Hygiene;Winter2001, Vol. 75 Issue 1, p9 

    Reports problem concerning the failure of subjects to adhere to a prescribed medication protocol in clinical trials. Observations of a poor patient compliance in clinical trials and practice; Reasons behind the failure of subjects to take the medications prescribed; Importance of patient...

  • ePRO: One Size Does Not Fit All. Muehihausen, Wilhelm // Applied Clinical Trials;Oct2010, Vol. 19 Issue 10, Special section p4 

    The article focuses on the significance of choice in electronic patient reported outcome (ePRO) solutions in clinical trials. It notes that the electronic initiatives such as the ePRO help streamline the clinical trials process and monitor patient safety. It also mentions that there are several...

  • The Future of ePRO. Bedford, Joseph // Applied Clinical Trials;Oct2010, Vol. 19 Issue 10, Special section p16 

    The article discusses the future of clinical trials with the advent of technological innovations. It highlights that pharmaceutical companies and drug developers are headed towards a patient-centric approach to data capture, using multiple collection formats. It also notes that patient related...

  • Relationship Between Satisfaction, Patient-Centered Care, Adherence and Outcomes Among Patients in A Collaborative Care Trial for Depression. Deen, Tisha; Fortney, John; Pyne, Jeffrey // Administration & Policy in Mental Health & Mental Health Service;Sep2011, Vol. 38 Issue 5, p345 

    Collaborative care is known to improve satisfaction, patient-centered care, adherence, and depression symptom severity. However, associations among these outcomes have not been examined. Outcomes were measured at 6 months for 360 primary care patients with depression enrolled in a randomized...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics